Click image to view original image
PharmaLegacy Laboratories (Shanghai) Co., Ltd is specialized in Business services,Medical service,Medical insurance since established in 10 years ago.So far,our company has established its branch companies in major cities throughout the country.Formed in Building 7, 388 Jialilue Road Zhangjiang High-Tech Park Pudong District Shanghai,Pudongxin District,City area,Shanghai,China as the center, the radiation sales system and service network.Details:Cell line-Derived Xenograft (CDX model) is a well-established and commonly used mouse tumor model type for the research and development of anti-tumor drugs and immunotherapy. More recently, human tumors implanted directly into immunodeficient mice have become increasingly popular as evidence accrues that they more accurately recapitulate features of patient tumors. However, CDX model still possesses pervasive application at the early stage of in vivo study, due to its user-friendly techniques as well as excellent repeatability.With decades of operational experience and technology platform of tumor cells, Pharmalegacy has established various well-validated cell-line-derived xenograft (CDX model) to satisfy your in vivo research, of which both solid tumors and precious hematological malignances models are available to customers. Our all-around products involve CDX model construction and delivery, in vivo projects execution as well as the final results presentation in the field of oncology research.
Adhering to the Sincere service, the pursuit of perfection spirit of enterprise, PharmaLegacy bases on long-term development, technology as the core, market-oriented, and constantly open up new areas, undertaking to provide fast, high-quality service for the vast numbers of users. For further information about PharmaLegacyPDX Modelx2a3868en, please visit our official website: www.pharmalegacy.com.
